The new Alexandra and Steven Cohen Pediatric Emergency Department at NewYork-Presbyterian Morgan Stanley Children's Hospital/Columbia University Medical Center opens today, significantly expanding access to the highest level of emergency pediatric care for families in the region.

Sharon Greenberger is joining NewYork-Presbyterian Hospital's management team as senior vice president for facilities development and engineering, effective today. She was most recently chief operating officer of the New York City Department of Education.

Among those presenting at this year's American Urological Association meeting are physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The meeting takes place May 14–19, at Walter E. Washington Convention Center, Washington, D.C.

You cast your eye on the table. Mmm… one after another, great heaping dishes of food — comfort food and holiday food. You dig in, savoring every bite. Now the meal is over and you are going through that terrible cycle of holiday remorse.

Dana Buchman, fashion designer and founder of the Promise Project, and Eugene Lang, entrepreneur and founder of the Lang Youth Medical Program and I Have A Dream Foundation, will each be honored with an Award for Distinguished Service by the Columbia Presbyterian Health Sciences Advisory Council.

To diagnose autism spectrum disorders, clinicians typically administer a variety of tests or scales and use information from observations and parent interviews to classify individuals into subcategories listed in standard psychiatric diagnostic manuals. This process of forming "best-estimate clinical diagnoses" has long been considered the gold standard, but a new study demonstrates that these diagnoses are widely variable across centers, suggesting that this may not be the best method for making diagnoses.

Patients with bipolar disorder may be eligible for a new clinical research study comparing two medications — quetiapine (Seroquel), a widely prescribed second-generation antipsychotic mood-stabilizing medication, and lithium, the gold-standard mood stabilizer.

Dr. Andrew B. Lassman has joined the Neurological Institute at NewYork-Presbyterian Hospital/Columbia University Medical Center as chief of neuro-oncology, a new program focusing on caring for patients with brain tumors and metastases as well as research into new treatments. Dr. Lassman has also been named to the faculty of Columbia University College of Physicians and Surgeons.